Chiang Mai University, Chiang Mai, Thailand.
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241261363. doi: 10.1177/15347354241261363.
To characterize the patterns of cannabis use among gynecologic cancer patients, in terms of potential factors influencing their decision-making on cannabis use, the reasons for use or non-use, and sources of information on cannabis use.
From March to July 2022, gynecologic cancer patients at a clinic were interviewed and classified into 3 groups: current users, ex-users, and never-users. The received data included: demographic data, cannabis use details, reasons for using and not using, adverse events, satisfaction, and intent to use. Univariate and multivariate analysis were used to identify risk factors influencing decision-making.
Among 240 participants, 11.67% were classified as current users, 28.33% as ex-users, and 60% as never-users. The significant factors influencing cannabis use decisions were advanced stage and receiving information on cannabis, regardless of the information source. The satisfaction derived from cannabis was due to the enhancement of mood and physical activity, improvement in sleep quality, stimulation of appetite, and mitigation of adverse events associated with cancer treatment. Approximately 60% of users aimed for a cancer cure. The main reasons for quitting were inability to obtain cannabis and absence of persistent cancer symptoms.
Among Thai patients with gynecologic cancer, 40% had a history of cannabis use. Advanced cancer stage was an independent factor for decision-making on cannabis use. Sources of information on cannabis are non-healthcare providers. Many patients intended to use cannabis for cancer cure. Also, many were satisfied with use because of a relief of unwanted symptoms, indirectly suggesting improvement in quality of life. The main reason for quitting was unavailability. The main reason for never trying was a concern of interference with treatment. Our results may guide the direction of strategy of cannabis use among patients with gynecologic cancers.
以影响患者使用大麻决策的潜在因素、使用或不使用的原因以及大麻使用信息来源为切入点，对妇科癌症患者的大麻使用模式进行分析。
2022 年 3 月至 7 月，对诊所的妇科癌症患者进行访谈，并将其分为三组：当前使用者、既往使用者和从不使用者。收集的数据包括：人口统计学数据、大麻使用细节、使用和不使用的原因、不良事件、满意度和使用意向。采用单变量和多变量分析来确定影响决策的风险因素。
在 240 名参与者中，11.67%被归类为当前使用者，28.33%为既往使用者，60%为从不使用者。影响大麻使用决策的显著因素是晚期癌症和获取大麻信息，无论信息来源如何。使用大麻的满意度来自于情绪和身体活动的改善、睡眠质量的提高、食欲的刺激以及减轻与癌症治疗相关的不良事件。大约 60%的使用者希望通过使用大麻来治愈癌症。退出的主要原因是无法获得大麻和没有持续的癌症症状。
在泰国患有妇科癌症的患者中，40%有使用大麻的历史。晚期癌症是决定是否使用大麻的独立因素。大麻信息来源是非医疗保健提供者。许多患者希望使用大麻来治疗癌症。此外，许多患者对使用大麻感到满意，因为他们的不适症状得到了缓解，这间接表明他们的生活质量得到了提高。退出的主要原因是无法获得大麻。从未尝试过的主要原因是担心会干扰治疗。我们的研究结果可能为妇科癌症患者使用大麻的策略提供指导。
